These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential. Lam B; Kung YJ; Lin J; Tseng SH; Tsai YC; He L; Castiglione G; Egbert E; Duh EJ; Bloch EM; Tobian AAR; Milstone AM; Roden RBS; Wu TC; Hung CF Cell Rep; 2021 Oct; 37(3):109838. PubMed ID: 34648735 [TBL] [Abstract][Full Text] [Related]
25. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron. Schröder S; Richter A; Veith T; Emanuel J; Gudermann L; Friedmann K; Jeworowski LM; Mühlemann B; Jones TC; Müller MA; Corman VM; Drosten C Virol J; 2023 Nov; 20(1):257. PubMed ID: 37940989 [TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern. Kovacech B; Fialova L; Filipcik P; Skrabana R; Zilkova M; Paulenka-Ivanovova N; Kovac A; Palova D; Rolkova GP; Tomkova K; Csokova NT; Markova K; Skrabanova M; Sinska K; Basheer N; Majerova P; Hanes J; Parrak V; Prcina M; Cehlar O; Cente M; Piestansky J; Fresser M; Novak M; Slavikova M; Borsova K; Cabanova V; Brejova B; Vinař T; Nosek J; Klempa B; Eyer L; Hönig V; Palus M; Ruzek D; Vyhlidalova T; Strakova P; Mrazkova B; Zudova D; Koubkova G; Novosadova V; Prochazka J; Sedlacek R; Zilka N; Kontsekova E EBioMedicine; 2022 Feb; 76():103818. PubMed ID: 35078012 [TBL] [Abstract][Full Text] [Related]
27. Review of the mechanisms of SARS-CoV-2 evolution and transmission. Chen J; Wang R; Wei GW ArXiv; 2021 Sep; ():. PubMed ID: 34545334 [TBL] [Abstract][Full Text] [Related]
28. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone. da Silva ES; Kohnen M; Gilson G; Staub T; Arendt V; Hilger C; Servais JY; Charpentier E; Domingues O; Snoeck CJ; Ollert M; Seguin-Devaux C; Perez-Bercoff D Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887023 [TBL] [Abstract][Full Text] [Related]
29. Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein. Lennerstrand J; Palanisamy N Viruses; 2021 Sep; 13(10):. PubMed ID: 34696404 [TBL] [Abstract][Full Text] [Related]
31. Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H. Zeng C; Evans JP; Faraone JN; Qu P; Zheng YM; Saif L; Oltz EM; Lozanski G; Gumina RJ; Liu SL mBio; 2021 Oct; 12(5):e0251021. PubMed ID: 34607452 [TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 Delta Variant: Interplay between Individual Mutations and Their Allosteric Synergy. Chan KC; Song Y; Xu Z; Shang C; Zhou R Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551170 [TBL] [Abstract][Full Text] [Related]
33. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern. Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487 [TBL] [Abstract][Full Text] [Related]
34. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern. Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802 [TBL] [Abstract][Full Text] [Related]
35. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations. Wu J; Zhang HX; Zhang J Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957 [TBL] [Abstract][Full Text] [Related]